These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 20662409

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Group-based and personalized care in an age of genomic and evidence-based medicine: a reappraisal.
    Maglo KN.
    Perspect Biol Med; 2012; 55(1):137-54. PubMed ID: 22643722
    [Abstract] [Full Text] [Related]

  • 24. Personalized medicine - the promised land: are we there yet?
    Li C.
    Clin Genet; 2011 May; 79(5):403-12. PubMed ID: 21204795
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Genetic basis of hypertension for the development of tailored medicine.
    Katsuya T, Morishita R, Rakugi H, Ogihrara T.
    Hypertens Res; 2009 Aug; 32(8):643-8. PubMed ID: 19543233
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Lexical fields of predictive and personalized medicine].
    Mathieu T, Bermont L, Boyer JC, Versuyft C, Evrard A, Cuvelier I, Couderc R, Peoc'h K.
    Ann Biol Clin (Paris); 2012 Aug; 70(6):651-8. PubMed ID: 23207809
    [Abstract] [Full Text] [Related]

  • 29. The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.
    Ross JS, Ginsburg GS.
    Am J Clin Pathol; 2003 Jan; 119(1):26-36. PubMed ID: 12520694
    [Abstract] [Full Text] [Related]

  • 30. Foundations, promises and uncertainties of personalized medicine.
    Bottinger EP.
    Mt Sinai J Med; 2007 Apr; 74(1):15-21. PubMed ID: 17516562
    [Abstract] [Full Text] [Related]

  • 31. Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.
    Ross CJ, Carleton B, Warn DG, Stenton SB, Rassekh SR, Hayden MR.
    Ann N Y Acad Sci; 2007 Sep; 1110():177-92. PubMed ID: 17911433
    [Abstract] [Full Text] [Related]

  • 32. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J.
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Pharmacogenomics: the quest for individualized therapy].
    López-López M, Guerrero-Camacho JL, Familiar-López IM, Jung-Cook H, Corona-Vázquez T, Alonso-Vilatela ME.
    Rev Neurol; 1999 Dec; 39(11):1063-71. PubMed ID: 15597270
    [Abstract] [Full Text] [Related]

  • 37. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics.
    Podgoreanu MV, Schwinn DA.
    J Am Coll Cardiol; 2005 Dec 06; 46(11):1965-77. PubMed ID: 16325027
    [Abstract] [Full Text] [Related]

  • 38. [Personalized medicine in psychiatry -- an old concept from a new aspect].
    Molnar JM.
    Neuropsychopharmacol Hung; 2012 Mar 06; 14(1):2-3. PubMed ID: 22427465
    [No Abstract] [Full Text] [Related]

  • 39. Prospects for personalized cardiovascular medicine: the impact of genomics.
    Ginsburg GS, Donahue MP, Newby LK.
    J Am Coll Cardiol; 2005 Nov 01; 46(9):1615-27. PubMed ID: 16256859
    [Abstract] [Full Text] [Related]

  • 40. Personalized medicine: changing the paradigm of drug development.
    Couch RD, Mott BT.
    Methods Mol Biol; 2012 Nov 01; 823():367-78. PubMed ID: 22081358
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.